The surge in the immunoassay market is mainly from the
rising occurrence of persistent conditions like cancer and
lifestyle-related ailments such as diabetes mellitus. Notably, the
uptick in different types of cancer, including breast and prostate
cancer, plays a pivotal role in driving market growth.
Additionally, heightened awareness about early disease detection
among individuals is further fueling the immunoassay market's
expansion throughout the projected period spanning 2024 to
2030.
LAS VEGAS, May 27, 2024 /PRNewswire/ -- DelveInsight's
Immunoassay Market Insights report provides the current
and forecast market analysis, individual leading immunoassay
companies' market shares, challenges, immunoassay market drivers,
barriers, trends, and key market immunoassay companies in the
market.
Key Takeaways from the Immunoassay Market Report
- As per DelveInsight estimates, North
America is anticipated to dominate the global immunoassay
market during the forecast period.
- Notable immunoassay companies such as Beckman Coulter, Inc., Siemens Healthcare GmbH,
F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher
Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare,
Werfen, Danaher Corporation, Sysmex Corporation, Awareness
Technology Inc, ZECEN Biotech Co., Quidel Corporation, and
several others, are currently operating in the immunoassay
market.
- In August 2023, Fapon
Biotech launched its latest chemiluminescence immunoassay
analyzer. The Shine i8000/9000 consists of innovative features and
has an ultra-high throughput of 900 tests per hour.
- In November 2022, Gethin
Biotech introduced the new MAGICAL 6000 chemiluminescence
immunoassay Analyzer at MEDICA.
- In April 2021, Snibe,
Diagnostic received CE marking for the Maglumi HIV Ab/Ag Combi
CLIA kit which detects HIV-1 and HIV-2 antibodies and the HIV-1 p24
antigen.
To read more about the latest highlights related to the
immunoassay market, get a snapshot of the key highlights entailed
in the Global Immunoassay Market Report
Immunoassay Overview
Immunoassay, a cornerstone in medical diagnostics,
revolutionizes the detection of various substances within
biological samples through the utilization of the immune system's
remarkable specificity. This technique harnesses the interaction
between antibodies and antigens, enabling the precise
identification and quantification of target molecules, such as
hormones, proteins, drugs, or infectious agents, in complex
biological matrices. Immunoassays encompass a diverse array of
methodologies, including enzyme-linked immunosorbent assays
(ELISA), radioimmunoassays (RIA), and chemiluminescent immunoassays
(CLIA), each offering distinct advantages tailored to specific
diagnostic needs. With its sensitivity, specificity, and
adaptability, immunoassay has become indispensable in clinical
laboratories, pharmaceutical research, environmental monitoring,
and beyond, driving advancements in healthcare and scientific
discovery.
The versatility of immunoassay extends beyond traditional
laboratory settings, finding applications in point-of-care
diagnostics, food safety testing, and forensic analysis. Its rapid
turnaround time, minimal sample requirements, and ease of
automation render immunoassays invaluable tools in screening large
populations for diseases, monitoring therapeutic drug levels, and
ensuring the safety and quality of consumables. Moreover, ongoing
innovations in immunoassay technology continue to enhance its
performance characteristics, enabling the detection of ever lower
concentrations of analytes with heightened precision. As the demand
for accurate, timely, and cost-effective diagnostic solutions
persists, immunoassay remains at the forefront, poised to meet the
evolving challenges of modern healthcare and scientific
inquiry.
Immunoassay Market Insights
In 2023, North America led the
Immunoassay market, largely due to prevalent unhealthy lifestyles
in the region leading to a significant number of people suffering
from lifestyle-related ailments like diabetes and thyroid
disorders. Factors such as strong disease awareness, government
backing, and a robust product development landscape further bolster
this market dominance.
A key driver of the North American immunoassay market is its
widespread application in detecting tumor markers indicative of
cancer progression. For example, in 2020, the National Cancer
Institute reported approximately 1.8 million cancer diagnoses in
the United States alone, with
specific cancers like prostate, lung, breast, and colorectal being
predominant.
Additionally, statistics from the Government of Canada in 2021 reveal cancer as a leading
cause of mortality, underlining the pressing need for early disease
detection and thus contributing to the immunoassay market's
expansion in the region.
Furthermore, the increasing prevalence of chronic conditions
such as coronary artery diseases and strokes among the US
population is another significant driver. According to the Centers
for Disease Control and Prevention, over 18 million adults in the
US had coronary artery disease in 2022, with approximately 805,000
experiencing heart attacks annually. These figures underscore the
critical role of immunoassay in identifying cardiac markers for
diagnosing cardiovascular disorders, thereby fostering immunoassay
market growth.
To know more about why North
America is leading the market growth in the immunoassay
market, get a snapshot of the Immunoassay Market
Outlook
Immunoassay Market Dynamics
The immunoassay market dynamics are continually evolving, driven
by advancements in technology, the increasing prevalence
of chronic diseases, and the growing demand for accurate
diagnostic tools. One of the key factors shaping the
immunoassay market is the rising focus on personalized
medicine, which necessitates precise and reliable immunoassays
for biomarker detection. This trend is fostering the development of
innovative immunoassay platforms capable of detecting multiple
analytes simultaneously, thereby enabling tailored treatment
strategies for patients.
Moreover, the global immunoassay market is influenced by the
expanding applications of immunoassays across various
sectors, including clinical diagnostics, pharmaceuticals, and
biotechnology. As healthcare providers and researchers seek to
enhance disease diagnosis and drug development processes, there is
a growing demand for high-throughput and sensitive immunoassay
techniques. This has led to the emergence of automated
immunoassay systems and multiplexing technologies, which offer
improved efficiency and cost-effectiveness, driving market
growth.
Additionally, factors such as increasing healthcare
expenditure, rising awareness about early disease detection,
and the adoption of immunoassay-based point-of-care testing
are fueling the immunoassay market expansion. Furthermore, the
COVID-19 pandemic has underscored the importance of rapid
and accurate diagnostic tests, leading to a surge in demand for
immunoassays for infectious disease detection. As the healthcare
industry continues to prioritize preventive healthcare and
precision medicine, the immunoassay market is poised for
significant growth and innovation in the coming years.
Get a sneak peek at the immunoassay market dynamics @
Immunoassay Market Dynamics Analysis
Report
Metrics
|
Details
|
Coverage
|
Global
|
Study Period
|
2021–2030
|
Immunoassay Market
CAGR
|
~8%
|
Key Immunoassay
Companies
|
Beckman Coulter, Inc.,
Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott
Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC
Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation,
Sysmex Corporation, Awareness Technology Inc, ZECEN Biotech Co.,
Quidel Corporation, among others
|
Immunoassay Market Assessment
- Immunoassay Market Segmentation
-
- Immunoassay Market Segmentation By Product: Reagents
& Kits and Instruments
- Immunoassay Market Segmentation By Technology:
Radioimmunoassay, Enzyme-Linked Immunoassay, Chemiluminescence
Immunoassay, Fluoroimmunoassay, and Others
- Immunoassay Market Segmentation By Sample: Blood, Urine,
Saliva, and Others
- Immunoassay Market Segmentation By Application:
Oncology, Cardiology, Infectious Disease Testing, Endocrinology,
Autoimmune Disorders, and Others
- Immunoassay Market Segmentation By End User: Hospitals
& Clinics, Diagnostic Labs, Pharmaceuticals & Biotech
Industries, and Others
- Immunoassay Market Segmentation By Geography:
North America, Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case
Studies, KOL's Views, Analyst's View
Which MedTech key players in the immunoassay market are set to
emerge as the trendsetter explore @ Immunoassay
Companies
Table of Contents
1
|
Report
Introduction
|
2
|
Executive
summary
|
3
|
Regulatory and Patent
Analysis
|
4
|
Key Factors
Analysis
|
5
|
Porter's Five Forces
Analysis
|
6
|
Immunoassay Market
Layout
|
7
|
Global Company Share
Analysis – Key 3-5 Companies
|
8
|
Immunoassay
Market Company and Product
Profiles
|
9
|
Project
Approach
|
10
|
About
DelveInsight
|
Interested in knowing the immunoassay market by 2030? Click to
get a snapshot of the Immunoassay Market Trends
Related Reports
Radioimmunoassay Market
Radioimmunoassay Market Insight, Competitive
Landscape, and Market Forecast – 2030 report delivers an
in-depth understanding of market trends, market drivers, market
barriers, and key radioimmunoassay companies, including
DIAsource, MP BIOMEDICALS, Merck KGaA, Tecan Trading AG, Svar
Life Science, Institute of Isotopes Co. Ltd., PerkinElmer Inc.,
Danaher Corporation, among others.
Chemiluminescence Immunoassay Market
Chemiluminescence Immunoassay Market Insight,
Competitive Landscape, and Market Forecast – 2030 report
delivers an in-depth understanding of market trends, market
drivers, market barriers, and key chemiluminescence immunoassay
companies, including Shenzhen Mindray Bio-Medical Electronics
Co., Ltd, Beckman Coulter, Inc.,
Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Maccura
Biotechnology Co., DiaSorin, Autobio, Diatron, Daan Gene Co., Ltd,
Trivitron Healthcare, Werfen, ALPCO, Medcaptain Medical Technology
Co., Ltd., ZECEN Biotech Co., Ltd, PHC Holdings Corporation,
Awareness Technology, Inc., Rayto Life and Analytical Sciences Co.,
Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd.,
Guangzhou Jinde Biotech Co., Ltd., among others.
ELISA Market
ELISA Market Insight, Competitive Landscape, and
Market Forecast – 2030 report delivers an in-depth
understanding of market trends, market drivers, market barriers,
and key ELISA companies, including Abbott, F. Hoffmann-La Roche
Ltd, Erba Mannheim, Synbiotik,
Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific,
DiaSorin, PerkinElmer Inc., Diatron, Werfen, ALPCO, Agilent, InBios
International Inc., Awareness Technology Inc., Elabscience
Biotechnology Inc., J. Mitra & Co. Pvt. Ltd., Rayto Life and
Analytical Sciences Co., Ltd., BD, Trivitron Healthcare, among
others.
Polymerase Chain Reaction Market
Polymerase Chain Reaction Market Insight,
Competitive Landscape, and Market Forecast – 2030 report
delivers an in-depth understanding of market trends, market
drivers, market barriers, and key PCR companies, including
Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc.,
Qiagen, Agilent Technologies Inc., Standard Biotools, F.
Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck
& Co. Inc., Abbott, Promega Corporation, Takara Bio Inc.,
Endress+Hauser Group Services AG, BioMérieux, GenMark Diagnostics
Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla,
among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports
pharma companies by providing comprehensive end-to-end solutions to
improve their performance.
Contact Us
Shruti
Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo:
https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/global-immunoassay-market-to-witness-growth-at-a-cagr-of-8-by-2030--delveinsight-302155911.html